The bioenergetic signature of isogenic colon cancer cells predicts the cell death response to treatment with 3-bromopyruvate, iodoacetate or 5-fluorouracil
<p>Abstract</p> <p>Background</p> <p>Metabolic reprogramming resulting in enhanced glycolysis is a phenotypic trait of cancer cells, which is imposed by the tumor microenvironment and is linked to the down-regulation of the catalytic subunit of the mitochondrial H<su...
Main Authors: | Cuezva José M, Sánchez-Aragó María |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-02-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/9/1/19 |
Similar Items
-
Short-term exposure of nontumorigenic human bronchial epithelial cells to carcinogenic chromium(VI) compromises their respiratory capacity and alters their bioenergetic signature
by: Joana F. Cerveira, et al.
Published: (2014-01-01) -
Validating the concept of mutational signatures with isogenic cell models
by: Xueqing Zou, et al.
Published: (2018-05-01) -
Delphinidin Increases the Sensitivity of Ovarian Cancer Cell Lines to 3-bromopyruvate
by: Natalia Pieńkowska, et al.
Published: (2021-01-01) -
3-Bromopyruvate Suppresses the Malignant Phenotype of Vemurafenib-Resistant Melanoma Cells
by: Patrik da Silva Vital, et al.
Published: (2022-12-01) -
Differentiate or Die: 3-Bromopyruvate and Pluripotency in Mouse Embryonic Stem Cells.
by: Ana Sofia Rodrigues, et al.
Published: (2015-01-01)